文献速递胃肠外科围术期管理与 ERAS

Roux-en-Y胃旁路术逆转的瑞典全国队列研究

Reversal of Roux-en-Y Gastric Bypass: A Swedish National Cohort Study.
PubMed 文献 · Ann Surg · 2026-04-27

该研究基于瑞典全国多中心回顾性队列,纳入2007至2023年间接受Roux-en-Y胃旁路术(RYGB)逆转的199例患者(84%女性,平均年龄42.5岁),逆转发生率为0.3%(63,797例RYGB中)。最常见指征为腹痛(70%)、营养不良(45%)、胃肠道症状(34%)和减重后低血糖(29%)。86%的患者获得部分或完全症状缓解,但早期严重并发症(Clavien-Dindo≥IIIb)发生率为24.6%,晚期严重并发症为21.6%。

要点

  • RYGB逆转罕见(0.3%),多因腹痛、营养不良、胃肠道症状及低血糖等严重并发症而考虑。
  • 86%患者症状缓解,减重后低血糖者缓解率最高(94.6%),但严重并发症常见。
  • 术后1年平均体重从77 kg增至89 kg,需权衡症状缓解与体重反弹及手术风险。

核心结论

  • RYGB逆转虽罕见,但对于并发症负担重的患者可考虑,多数患者可获得症状缓解,但术后并发症常见。

研究设计与样本

  • 瑞典全国多中心回顾性队列研究,纳入2007至2023年接受RYGB逆转的全部199例患者,数据来自斯堪的纳维亚肥胖手术注册中心(SOReg)和医疗记录。

主要发现

  • 逆转发生率为0.3%(199/63,797例RYGB),患者84%为女性,平均年龄42.5岁。
  • 最常见指征为腹痛(70%)、营养不良(45%)、胃肠道症状(34%)和减重后低血糖(29%)。
  • 84%手术经腹腔镜完成,中位住院4天;平均体重从逆转时77 kg增至1年时89 kg。
  • 86%患者报告部分或完全症状缓解,减重后低血糖者缓解率最高(94.6%)。
  • 早期严重并发症(Clavien-Dindo≥IIIb)发生率为24.6%,晚期严重并发症为21.6%,随访期间7例非手术相关死亡(3.5%)。

临床怎么用

  • 对RYGB后出现严重并发症(如顽固性腹痛、营养不良、低血糖)的患者,可评估逆转手术的获益与风险。
  • 术前需仔细选择患者、优化围术期管理,并设定 realistic 预期,充分告知高并发症风险和体重反弹可能。

局限性

  • 回顾性队列设计,缺乏非手术对照组,无法比较逆转与保守治疗的效果。
  • 部分数据依赖注册中心和医疗记录,可能存在信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess incidence, indications, symptom relief, complications, and weight outcomes following Roux-en-Y gastric bypass (RYGB) reversal. BACKGROUND: RYGB is an effective treatment for obesity but may in rare cases be associated with severe long-term complications requiring RYGB reversal. Evidence on incidence and outcomes is limited. METHODS: This nationwide, multi-center, retrospective cohort study included all patients undergoing RYGB reversal in Sweden between 2007 and 2023. Data were obtained from the Scandinavian Obesity Surgery Registry (SOReg) and medical records. RESULTS: During the study period, 199 patients (84% female, mean age 42.5 y) underwent RYGB reversal at 13 centers, corresponding to an incidence of 0.3% of 63,797 RYGB-procedures performed. Patients usually had multiple indications, most often abdominal pain (70%), malnutrition (45%), gastrointestinal symptoms (34%), and postbariatric hypoglycemia (29%). Most procedures (84%) were performed laparoscopically, with a median hospital stay of 4 days. Mean body weight increased from 77 kg at reversal to 89 kg at one year. Overall, 86% of patients reported partial or complete symptom relief, highest rates among those with postbariatric hypoglycemia (94.6%). Early severe complications (Clavien-Dindo grade ≥IIIb) occurred in 24.6% and late severe complications in 21.6%, with seven not surgery-related deaths (3.5%) during follow-up. CONCLUSIONS: Reversal of RYGB is rare but can be considered in patients with a substantial burden of complications. Although postoperative morbidity was common, most patients achieved symptom relief. Careful patient selection, perioperative optimization, and realistic expectations are essential. Further studies are needed to determine optimal surgical techniques and long-term outcomes.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Sillén L, Hansson E, Rellme D, et al. Reversal of Roux-en-Y Gastric Bypass: A Swedish National Cohort Study. Ann Surg. 2026. PMID: 42041235. doi:10.1097/SLA.0000000000007074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。